New insights on SOM230, a universal somatostatin receptor ligand.

Journal of endocrinological investigation

Volumn 26, Issue 8 Suppl, 2003, Pages 14-16

  Boerlin, V ^a   van der Hoek, J ^a   Beglinger, C ^a   Poon, K W ^a   Hartmann, S ^a   Dutreix, C ^a   Kovarik, J M ^a   Bruns, C ^a   Weckbecker, G ^a   Lewis, I ^a   Schnieper, P ^a   Hofland, L J ^a   Lamberts, S W ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; HUMAN GROWTH HORMONE; NEW DRUG; OCTREOTIDE; PASIREOTIDE; SOM-230; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ACROMEGALY; ARTICLE; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; DRUG TOLERANCE; METABOLISM; NAUSEA; PHASE 1 CLINICAL TRIAL; REFERENCE VALUE; SECRETION; VOMITING;

ACROMEGALY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; DRUG TOLERANCE; DRUGS, INVESTIGATIONAL; HUMAN GROWTH HORMONE; NAUSEA; OCTREOTIDE; RECEPTORS, SOMATOSTATIN; REFERENCE VALUES; SOMATOSTATIN; VOMITING;

EID: 3543103117     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)